Friday 6 November 2026 Export ARWR’s income statement to Excel — free account

Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $829.4 million, up 23,258.2% from fiscal 2024.

Revenue: +171.0%
EPS: −7.94%
Free cash flow: −15.4%
Total debt: +259.5%

Quarter to June 2026, against a year earlier

58.19 0.73 +1.27%

Follow ARWR

Alert me

Market cap: $8.1B
P/E: 0.0×
Fwd P/E: −16.6×
Dividend yield: —
F-score: 5/9
Altman Z: 2.98
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Valuation Filings

Arrowhead Pharmaceuticals, Inc. (ARWR) P/E ratio

Alert me on P/E ratio

Arrowhead Pharmaceuticals, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 481× (June 2020) — the current reading is the lowest in ten years.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/ARWR/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Arrowhead Pharmaceuticals, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/ARWR/metrics/pe-ratio">Arrowhead Pharmaceuticals, Inc. (ARWR) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	0.0×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	0.0×	—
FY2020	0.0×	—
FY2019	40.8×	—
FY2018	0.0×	—
FY2017	0.0×	—
FY2016	0.0×	—

Period	P/E ratio	Change
Jun 2026	0.0×	—
Mar 2026	0.0×	—
Dec 2025	43.4×	—
Sep 2025	0.0×	—
39 more quarters	Free account

Against its own ten years

Low 0.0× High 481×

Ten-year median 0.0×

Current reading's percentile 87

Company	P/E ratio
TWST Twist Bioscience Corporation compare	n/m
SYRE Spyre Therapeutics, Inc. compare	n/m
CYTK Cytokinetics, Incorporated compare	n/m
MDGL Madrigal Pharmaceuticals, Inc. compare	n/m
ARWR Arrowhead Pharmaceuticals, Inc.	n/m
KRYS Krystal Biotech, Inc. compare	39.2×
CORT Corcept Therapeutics Incorporated compare	47.5×
CAI Caris Life Sciences,�Inc. compare	77.7×
PTGX Protagonist Therapeutics, Inc. compare	111×
Biotechnology industry median	10.3×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Arrowhead Pharmaceuticals, Inc. (ARWR) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ARWR

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on ARWR

Stockrow Weekly